The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (NYSE:BMY), AbbVie (NYSE:ABBV), Roche (OTC:RHHBY), Johnson & Johnson (NYSE:JNJ), and AstraZeneca (NASDAQ:AZN) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.